Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder

Summary

The objective of Study A is to evaluate the efficacy of risperidone on the 4 behavioral dimensions of Berderline Personality Disorder (BPD)in an open label trial:mood swings, impulsivity, thing difficulties and disturbed relationships. The secondary objective of this study (Study B)is to validate a self-report measure of clinical symptoms specific to the treatment of patients with BPD, the UAB Borderline Rating Scale(BRS).

Timeline

Start

2003-07

Primary completion

2007-10

Completion

2007-10

Drugs

Indications